ArticleAnnals of the rheumatic diseases2016
Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.